PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

NCT02584647 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment

Conditions

Sarcoma
Malignant Peripheral Nerve Sheath Tumors

Interventions

DRUG: PLX3397
DRUG: sirolimus

Sponsor

Gulam Manji

Collaborators

[object Object]